ANZCTR search results

These search results are from the Australian New Zealand Clinical Trials Registry (ANZCTR).

You can narrow down the results using the filters

31620 results sorted by trial registration date.
  • The Southern Adelaide Waiting List Project: A Regional Partners in Health Approach with a Call-Centre Support System

  • The role of Dipyridamole in Improving the False Negative Rate in Pre-Operative Parathyroid Adenoma Localisation Using 99mTc Sestamibi

  • A phase II trial of high dose cytarabine and fludarabine without anthracycline for patients with core binding factor acute myeloid leukaemia, measuring efficacy, safety and monitoring minimal residual disease

    This trial is assessing the outcome of patients with a rare form of AML (CBF-AML) who have anthracyline (or not) as part of their treatment

  • Passive joint mobilisation for the treatment of shoulder pain

    Forty subjects presenting with pain during shoulder movements will be recruited for this study. Subjects will be randomly allocated into either a control or experimental group. Both groups will receive advice and shoulder exercises. The experimental group will additionally receive passive shoulder joint mobilisation. Outcome measurements of pain intensity, functional impairment, self assessment of improvement and active range of movement will be re-assessed by a blinded researcher at 1, 3 and 6 months following recruitment.

  • Is regional anaesthesia associated with postoperative cognitive deficit? A prospective randomised controlled trial.

  • The Early Nasojejunal Tube to Meet Energy Requirements in Intensive Care Study

    study completed and published Conclusions: In mechanically ventilated patients with mildly elevated gastric residual volumes and already receiving nasogastric nutrition, early nasojejunal nutrition did not increase energy delivery and did not appear to reduce the frequency of pneumonia. The rate of minor gastrointestinal hemorrhage was increased. Routine placement of a nasojejunal tube in such patients is not recommended.

  • Beta-blockers and Airways Disease

  • The DRIP Trial

    Most hospitals re-site peripheral intravenous catheters in adults every 72-96 hours, based on current Centers of Disease Control and Prevention Guidelines. This is at odds with regimes for children, and critically ill patients, where cannulas are only re-sited when clinically indicated. Recent prospective surveillance studies have demonstrated the safety of longer dwell times but these observations have not been validated in adults, using randomised controlled trial methodology. The primary aim of the present study is to compare the rates of peripheral catheter-related local infection, phlebitis and obstruction between two groups of patients - those having routine catheter changes every 72 hours and those having catheter changes only when clinically indicated.

  • Redback Spider AntiVenom Evaluation (RAVE) Study

    The study has been published A randomised controlled trial of intramuscular vs. intravenous antivenom for latrodectism--the RAVE study. Isbister GK, Brown SG, Miller M, Tankel A, Macdonald E, Stokes B, Ellis R, Nagree Y, Wilkes GJ, James R, Short A, Holdgate A. QJM. 2008 Jul;101(7):557-65.

  • Repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of depression.

    This study is designed to evaluate the therapeutic application of repetitive transcranial magnetic stimulation (rTMS) as a potential treatment for depression.

Tags:
  • Finding clinical trials